Skip to main content

Research Repository

Advanced Search

FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects

Brunt, A.M.; Haviland, J.; Sydenham, M.; Al-hasso, A.; Bloomfield, D.; Chan, C.; Churn, M.; Cleator, S.; Coles, C.; Emson, M.; Goodman, A.; Griffin, C.; Harnett, A.; Hopwood, P.; Kirby, A.; Kirwan, C.; Morris, C.; Sawyer, E.; Somaiah, N.; Syndikus, I.; Wilcox, M.; Zotova, R.; Wheatley, D.; Bliss, J.; Yarnold, J.

Authors

J. Haviland

M. Sydenham

A. Al-hasso

D. Bloomfield

C. Chan

M. Churn

S. Cleator

C. Coles

M. Emson

A. Goodman

C. Griffin

A. Harnett

P. Hopwood

A. Kirby

C. Kirwan

C. Morris

E. Sawyer

N. Somaiah

I. Syndikus

M. Wilcox

R. Zotova

D. Wheatley

J. Bliss

J. Yarnold



Abstract

Meeting abstract.

Citation

Brunt, A., Haviland, J., Sydenham, M., Al-hasso, A., Bloomfield, D., Chan, C., …Yarnold, J. (2018). FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects. Radiotherapy and Oncology, 127(S1), S311 -S312. https://doi.org/10.1016/S0167-8140%2818%2930905-8

Journal Article Type Conference Paper
Conference Name ESTRO 37, April 20-24, 2018
Conference Location Barcelona, Spain
Acceptance Date Apr 1, 2018
Publication Date Apr 1, 2018
Journal Radiotherapy and Oncology
Print ISSN 0167-8140
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 127
Issue S1
Pages S311 -S312
DOI https://doi.org/10.1016/S0167-8140%2818%2930905-8
Publisher URL http://doi.org/10.1016/S0167-8140(18)30905-8